Christine Goldstine

Christine Goldstine has extensive experience at Bristol Myers Squibb, holding various positions since August 1993, including Associate Director of Capital Asset Assessment & Acquisition Lead, Capital Resource Optimization Manager, and Research Scientist II. Prior to this, Christine collaborated as a Research Scientist II at Bristol-Myers Squibb PRI and in Princeton, New Jersey from 1993 to June 2020, as well as serving as a Research Scientist II in earlier roles until 2010. Christine began a career as a Scientist at American Cyanamid from 1992 to 1993. Academic qualifications include a Master of Science in Cellular Biology from Georgian Court University and a Bachelor of Science in Biology with a Pre-Med focus from Rider University.